Testing effectiveness (Phase 2)Ended earlyNCT05016622What this trial is testingBooster Dose TrialWho this might be right forCancer Montefiore Medical Center 106
Not applicableEnded earlyNCT04852822What this trial is testingImmune Response to SARS-CoV-2 (COVID-19) Vaccines in Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic LymphomaWho this might be right forChronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma University of Washington 350
Testing effectiveness (Phase 2)Study completedNCT04436471What this trial is testingAn Open Study of the Safety, Tolerability and Immunogenicity of the Drug "Gam-COVID-Vac" Vaccine Against COVID-19Who this might be right forPreventive Immunization COVID-19 Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation 38
Not applicableUnknownNCT05387252What this trial is testingGlucoside- and Rutinoside-rich Crude Material for Relieving Side Effects of COVID-19 VaccinesWho this might be right forVaccine Adverse ReactionSide-Effect Taipei Medical University 93
Post-approval studies (Phase 4)Study completedNCT04747821What this trial is testingAn Effectiveness Study of the Sinovac's Adsorbed COVID-19 (Inactivated) VaccineWho this might be right forCovid19 Butantan Institute 27,711
Testing effectiveness (Phase 2)Study completedNCT05305573What this trial is testingAssessing the Immunogenicity and Safety of a HIPRA's Candidate Booster Vaccination in Adults Fully Vaccinated With Adenovirus Vaccine Against COVID-19.Who this might be right forCOVID-19SARS-CoV-2 Acute Respiratory Disease Hipra Scientific, S.L.U 26
Testing effectiveness (Phase 2)Study completedNCT04441047What this trial is testingUniversal Anti-Viral Vaccine for Healthy Elderly AdultsWho this might be right forVirus DiseasesPneumoniaCOVID-19 Respiratory Infection+3 more Mirror Biologics, Inc. 40
Large-scale testing (Phase 3)Ended earlyNCT04860258What this trial is testingCOVID-19: A Study to Evaluate Safety, Reactogenicity and Immunogenicity of the SARS-CoV-2 mRNA Vaccine CVnCoV in Adults With Co-morbiditiesWho this might be right forCoronavirusCovid19SARS-CoV-2+1 more CureVac 129
Not applicableUnknownNCT06357650What this trial is testingCollaborative Open Research Initiative Study (CORIS-1)Who this might be right forPatient EngagementCOVID-19Preventable Disease, Vaccine+7 more Chisquares Incorporated 15,000
Large-scale testing (Phase 3)Study completedNCT04651790What this trial is testingEfficacy, Safety, and Immunogenicity of Two Vaccination Schedules of an Inactivated Vaccine Against COVID-19 in AdultsWho this might be right forCovid19Vaccines Pontificia Universidad Catolica de Chile 2,300
Not applicableLooking for participantsNCT05553743What this trial is testingResearchers At UC San Diego Are Learning About the Benefits of Human Milk and How It Influences Infant and Child HealthWho this might be right forBreastfeedingCOVID-19 InfectionCOVID-19 Vaccine+2 more University of California, San Diego 5,000
Not applicableStudy completedNCT05993260What this trial is testingUsing Text Messages to Boost COVID-19 Vaccine Booking RateWho this might be right forVaccination HesitancyCOVID-19 The Behavioural Insights Team 1,825,937
Large-scale testing (Phase 3)Looking for participantsNCT07655180What this trial is testingSafety and Serum Virus Neutralizing Antibody Responses of VYD2311, a COVID-19 Vaccine, and Coadministered VYD2311 With a COVID-19 VaccineWho this might be right forCOVID-19 Invivyd, Inc. 210
Post-approval studies (Phase 4)Not Yet RecruitingNCT07790523What this trial is testingEffectiveness of An Influenza/COVID-19 Vaccine (mCombriax [mRNA-1083]) in Adults ≥ 65 YearsWho this might be right forCOVID-19Influenza Tor Biering-Sørensen 410,000
Large-scale testing (Phase 3)Study completedNCT04816669What this trial is testingEvaluate Safety, Tolerability, & Immunogenicity of Multiple Formulations of BNT162b2 Against COVID-19 in Healthy AdultsWho this might be right forSARS-CoV-2 InfectionCOVID-19 BioNTech SE 629
Not applicableUnknownNCT05171959What this trial is testingPlatelet and Immune Response in Covid-19 VaccineWho this might be right forSARS-CoV-2 Vaccination University of Roma La Sapienza 32
Testing effectiveness (Phase 2)Study completedNCT04944368What this trial is testingPhase II Clinical Trial of CinnaGen COVID-19 Vaccine (SpikoGen)Who this might be right forCovid19 Cinnagen 400
Not applicableUnknownNCT05084950What this trial is testingInforming the Population of Their Level of Protection Against COVID-19 in Monaco: a Prospective Study (MonaVacc)Who this might be right forSARS-CoV-2COVID-19Vaccines+1 more Centre Scientifique de Monaco 10,000
Early research (Phase 1)UnknownNCT05003479What this trial is testingClinical Trial of SARS-CoV-2 Vaccine (Vero Cells), Inactivated in Healthy Population Aged 3 to 17 Years(COVID-19)Who this might be right forCOVID-19 Shenzhen Kangtai Biological Products Co., LTD 84
Large-scale testing (Phase 3)Study completedNCT05381350What this trial is testingImmunogenicity and Safety of Booster Immunization of COVID-19 Vaccine (Vero Cell), Inactivated (Omicron Variant) in Healthy People Aged 18 Years and AboveWho this might be right forCOVID-19 Sinovac Research and Development Co., Ltd. 1,750